| Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... The lancet Diabetes & endocrinology 9 (2), 82-93, 2021 | 330 | 2021 |
| Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature TM Caparrotta, DJ Antoine, JW Dear European journal of clinical pharmacology 74, 147-160, 2018 | 117 | 2018 |
| Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose JM Pettie, TM Caparrotta, RW Hunter, EE Morrison, DM Wood, PI Dargan, ... EClinicalMedicine 11, 11-17, 2019 | 71 | 2019 |
| Rapid epidemiological analysis of comorbidities and treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): a population-based case-control study PM McKeigue, A Weir, J Bishop, SJ McGurnaghan, S Kennedy, ... PLoS Medicine 17 (10), e1003374, 2020 | 70 | 2020 |
| Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland PM McKeigue, S McGurnaghan, L Blackbourn, LE Bath, DA McAllister, ... Diabetes care 46 (5), 921-928, 2023 | 65 | 2023 |
| PEGylated insulin Lispro,(LY2605541)—a new basal insulin analogue TM Caparrotta, M Evans Diabetes, Obesity and Metabolism 16 (5), 388-395, 2014 | 64 | 2014 |
| Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study PM McKeigue, S Kennedy, A Weir, J Bishop, SJ McGurnaghan, ... BMC medicine 19, 1-11, 2021 | 53 | 2021 |
| Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group. Risks of and risk factors for COVID-19 disease in people … SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... Lancet Diabetes Endocrinol 9 (2), 82-93, 2021 | 49 | 2021 |
| The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study SJ McGurnaghan, L Brierley, TM Caparrotta, PM McKeigue, ... Diabetologia 62, 621-632, 2019 | 41 | 2019 |
| Sodium–glucose co-transporter 2 inhibitors (SGLT2i) exposure and outcomes in type 2 diabetes: a systematic review of population-based observational studies TM Caparrotta, AM Greenhalgh, K Osinski, RM Gifford, S Moser, SH Wild, ... Diabetes Therapy 12, 991-1028, 2021 | 34 | 2021 |
| Development and validation of a cardiovascular risk prediction model in type 1 diabetes SJ McGurnaghan, PM McKeigue, SH Read, S Franzen, AM Svensson, ... Diabetologia 64 (9), 2001-2011, 2021 | 25 | 2021 |
| Risks of and risk factors for COVID‑19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021; 9 (2): 82–93 SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... Diabetes Res Clin Pract 167, 108354, 2020 | 25 | 2020 |
| Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland A Jeyam, FW Gibb, JA McKnight, B Kennon, JE O’Reilly, TM Caparrotta, ... Diabetologia 64, 1320-1331, 2021 | 22 | 2021 |
| Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide … A Jeyam, FW Gibb, JA McKnight, JE O’Reilly, TM Caparrotta, A Höhn, ... Diabetologia 65, 159-172, 2022 | 21 | 2022 |
| Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision‐making TM Caparrotta, JW Dear, HM Colhoun, DJ Webb British journal of clinical pharmacology 85 (9), 1907-1924, 2019 | 20 | 2019 |
| Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study PM McKeigue, S Kennedy, A Weir, J Bishop, SJ McGurnaghan, ... medRxiv, 2020.07. 23.20160747, 2020 | 17 | 2020 |
| Prescribing paradigm shift? Applying the 2019 European Society of Cardiology–led guidelines on diabetes, prediabetes, and cardiovascular disease to assess eligibility for … TM Caparrotta, LAK Blackbourn, SJ McGurnaghan, J Chalmers, ... Diabetes Care 43 (9), 2034-2041, 2020 | 15 | 2020 |
| Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017 JE O’Reilly, LAK Blackbourn, TM Caparrotta, A Jeyam, B Kennon, ... Diabetologia 63, 1626-1636, 2020 | 15 | 2020 |
| Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in Scotland: a nationwide retrospective cohort observational study JE O’Reilly, A Jeyam, TM Caparrotta, J Mellor, A Hohn, PM McKeigue, ... Diabetes Care 44 (9), 2010-2017, 2021 | 13 | 2021 |
| Cohort profile: the Scottish Diabetes Research Network national diabetes cohort–a population-based cohort of people with diabetes in Scotland SJ McGurnaghan, LAK Blackbourn, TM Caparrotta, J Mellor, A Barnett, ... BMJ open 12 (10), e063046, 2022 | 12 | 2022 |
